Xarelto is a prescription medication used to prevent blood clots and reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and to reduce the risk of DVT and PE in certain patients who have undergone hip or knee replacement surgery. The typical dosage for these indications is 20 mg once daily [1].
How Much Does Xarelto 20 mg Cost?
The price of Xarelto 20 mg can vary significantly based on factors such as insurance coverage, pharmacy, and location. Without insurance, a 30-day supply can range from approximately $300 to over $600 [2]. Discount cards and patient assistance programs may help reduce out-of-pocket costs for eligible individuals [3].
Are There Cheaper Alternatives to Xarelto?
Yes, there are other anticoagulant medications available that may be prescribed as alternatives to Xarelto. These include other direct oral anticoagulants (DOACs) like Eliquis (apixaban) and Pradaxa (dabigatran), as well as warfarin, a vitamin K antagonist [4]. The cost of these alternatives can also vary.
When Does Xarelto's Patent Expire?
Information regarding specific patent expiry dates for Xarelto (rivaroxaban) is complex and can involve multiple patents covering different aspects of the drug, such as its composition, formulation, and methods of use. DrugPatentWatch.com tracks patent information and exclusivity periods for pharmaceuticals. Detailed patent information can be found on specialized patent databases [5].
Can Generic Versions of Xarelto Be Purchased?
As of late 2023, generic versions of Xarelto were not yet widely available in major markets like the United States, although some generic options may be emerging in other regions or for specific formulations [6]. The availability of generics typically follows the expiry of key patents and regulatory approvals.
How Does Xarelto Compare to Other Blood Thinners?
Xarelto is a direct oral anticoagulant (DOAC). Unlike warfarin, which requires regular blood monitoring, DOACs generally do not require routine laboratory monitoring and have fewer dietary restrictions [4]. When compared to other DOACs like Eliquis and Pradaxa, Xarelto has demonstrated comparable efficacy and safety profiles in clinical trials, though specific advantages or disadvantages may exist depending on the indication and individual patient factors [7].
What are the Risks and Side Effects of Xarelto?
The most significant risk associated with Xarelto, like other anticoagulants, is bleeding. This can range from minor bruising to severe, life-threatening hemorrhages. Other common side effects can include nausea, vomiting, dizziness, and fatigue [1]. Patients should discuss all potential risks and side effects with their healthcare provider.
Who Manufactures Xarelto?
Xarelto is co-developed and jointly marketed by Bayer and Janssen Pharmaceuticals [8].
Sources:
1. https://www.drugs.com/xarelto.html
2. https://www.goodrx.com/xarelto
3. https://www.pparx.org/
4. https://www.mayoclinic.org/diseases-conditions/deep-vein-thrombosis/diagnosis-treatment/drc-20352563
5. https://drugpatentwatch.com/
6. https://www.ashp.org/drug-synthesis/drug-review/drug-shortages
7. https://www.nejm.org/doi/full/10.1056/NEJMoa1010157
8. https://www.janssen.com/our-products